Chairman & Chief Executive Officer
United States of America
Rosellini, a former minor-league pitcher,holds five master’s degrees in addition to a law degree. He is a 15-year veteran of the neurotechnology space and has expertise in accelerating the development of emerging technologies with minimal at-risk capital. He previously founded and led Lexington Technology Group, LLC, a database company commercializing a database solution with an exit to ("DSS" NYSE) Sarif Biomedical LLC, a stereotactic microsurgery company exit to ("MARA" NSDQ). He became a board member of Marathon Patent Group ("MARA") in 2013. Rosellini also founded Microtransponder in 2006. In 2012, Rosellini left his position as CEO at Microtransponder after temporarily losing his voice to thyroid cancer. After making a full recovery and with Microtransponder under talented management, Rosellini went on to a new venture via acquisition of technology and intellectual property, launching preclinical and clinical programs, and raising non-dilutive and at-risk capital to support the launch of Nexeon's next generation of viable medical technology products and associated remote management software platforms. Watch Rosellini's 2015 Ted Talk: Turning Bodies into Cars to learn more about his vision.
neurotechnology,viable medical technology products and associated remote management software platforms.